The tumor suppressor PTEN dephosphorylates the lipid second messenger, phosphoinositol 3,4,5-trisphosphate (PIP3), an enzymatic product PI3K, and negatively regulates survival signaling mediated by PI3K/Akt (PI3K/Akt) [13, 14]. This evidence concerns the gene AKT1 and neoplasm.